Revvity's Earnings: Will It Spark a Rally?

Revvity, a life sciences giant, is set to release its earnings report on Tuesday, with investors anticipating a significant six point one percent year-over-year revenue increase. The company has a strong track record of meeting revenue estimates, and its peers have shown mixed results, with Avantor going flat and Thermo Fisher growing six point two percent. The broader life sciences tools sector has seen a six percent increase in shares over the last month, but Revvity has lagged at a two point four percent decrease. Analysts predict an upside with an average price target of one hundred thirteen dollars ninety-three cents, which could potentially reverse Revvitys recent dip if they deliver as expected. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/d45385ff7e68a31d